SCHEMBL14354573

SCHEMBL14354573

CN1C(=CC2=C(O)C(=CC3=[N+](C)c4cc5c(cc4C3(C)C)[N+](C)=C(/C=C3\C(O)=C(/C=C4/N(C)c6ccccc6C4(C)C)C3=C(C#N)C#N)C5(C)C)C2=C(C#N)C#N)C(C)(C)c2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 12/20 0.43
KMT2A Q03164 12/20 0.43
MAPT P10636 12/20 0.43
HTT P42858 8/20 0.43
CRHBP P24387 3/20 0.43
CRHR2 Q13324 3/20 0.43
KEAP1 Q14145 1/20 0.43
NFE2L2 Q16236 1/20 0.43
RAB9A P51151 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
LMNA P02545 10/20 0.39
KDM4E B2RXH2 5/20 0.39
MAPK1 P28482 4/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
TDP1 Q9NUW8 3/20 0.39
ALDH1A1 P00352 5/20 0.37
TSHR P16473 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14199092 0.94 MEN1 (0.44) MEN1KMT2AMAPTHTTCRHBP
SCHEMBL25986998 0.83 VDR (0.35) MEN1KMT2AMAPTHTTCRHBP
SCHEMBL14199091 0.82 MEN1 (0.41) MEN1KMT2AMAPTHTTCRHBP
SCHEMBL14453260 0.79 MAPT (0.41) MEN1KMT2AMAPTHTTCRHBP
SCHEMBL16520776 0.78 RAB9A (0.45) MEN1KMT2AMAPTHTTCRHBP
SCHEMBL25987253 0.78 PRMT1 (0.40) MEN1KMT2AMAPTHTTCRHBP
SCHEMBL14227547 0.78 LMNA (0.42) MEN1KMT2AMAPTHTTCRHBP
SCHEMBL15996382 0.78 LMNA (0.44) MEN1KMT2AMAPTHTTCRHBP
SCHEMBL12690873 0.78 LMNA (0.44) MEN1KMT2AMAPTHTTCRHBP
SCHEMBL13084302 0.78 LMNA (0.44) MEN1KMT2AMAPTHTTCRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070281363-A1 Reporter molecules based on squaric, croconic, and/or rhodizonic acid; photoluminescence Terpetschnig, Ewald (US) 2007-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070281363-A1 Reporter molecules based on squaric, croconic, and/or rhodizonic acid; photoluminescence SPR, SRRT, SQLE MEN1 2672/4885KMT2A 3474/4885MAPT 3790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.